Approvals & regulatory · first seen 4h ago, updated 4h ago
Prime Medicine stock jumps 8% after FDA clears PM647 trial
Coverage 1 article · 1 outlet
-
Seeking Alpha HealthcarePrime Medicine stock jumps 8% after FDA clears PM647 trial